A share price of Evolent Health Inc [EVH] is currently trading at $12.54, down -0.48%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EVH shares have gain 9.14% over the last week, with a monthly amount glided 13.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on January 10, 2025, when Needham initiated its Buy rating and assigned the stock a price target of $15. Previously, BTIG Research reaffirmed its Buy rating on December 03, 2024, and dropped its price target to $29. On November 08, 2024, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $16 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $35 on October 11, 2024. Truist upgraded its rating to a Buy and raised its price target to $33 on August 09, 2024. Citigroup started tracking with a Buy rating for this stock on April 22, 2024, and assigned it a price target of $40. In a note dated March 01, 2024, Oppenheimer initiated an Outperform rating and provided a target price of $45 on this stock.
Evolent Health Inc experienced fluctuations in its stock price throughout the past year between $10.53 and $35.00. Currently, Wall Street analysts expect the stock to reach $33 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $12.54 at the most recent close of the market. An investor can expect a potential return of 163.16% based on the average EVH price forecast.
Analyzing the EVH fundamentals
Trailing Twelve Months sales for Evolent Health Inc [NYSE:EVH] were 2.46B which represents 21.60% growth. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.07 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.09 points at the first support level, and at 11.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.99, and for the 2nd resistance point, it is at 13.43.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Evolent Health Inc [NYSE:EVH] is 1.04. Further, the Quick Ratio stands at 1.04, while the Cash Ratio is 0.18. Considering the valuation of this stock, the price to sales ratio is 0.59, the price to book ratio is 1.39.
Transactions by insiders
Recent insider trading involved McCarthy Daniel Joseph, PRESIDENT, that happened on Aug 22 ’24 when 23693.0 shares were sold. PRESIDENT, McCarthy Daniel Joseph completed a deal on Aug 23 ’24 to sell 10469.0 shares. Meanwhile, General Counsel Weinberg Jonathan sold 42140.0 shares on Aug 22 ’24.
